<DOC>
	<DOCNO>NCT02185430</DOCNO>
	<brief_summary>COPD often associate airflow limitation pulmonary hyperinflation . During one-lung ventilation ( OLV ) , COPD patient ' physiologic dead space increase hypercapnia may develop . In addition , alveolar overdistention pulmonary hyperinflation would divert pulmonary blood flow impair arterial oxygenation . Dexmedetomidine vasoconstricting vasodilatatory effect peripheral vasculature smooth muscle effect bronchial smooth muscle unknown . The investigator evaluate effect dexmedetomidine ( bolus 1.0 μg kg-1 10 min follow continuous infusion 0.5 μg kg-1 h-1 infusion one-lung ventilation ) bronchodilator COPD patient administer surgery one lung ventilation . If result successfully show effect dexmedetomidine predominantly vasodilator bronchial tree , investigator study support dexmedetomidine vasodilator pulmonary vessel bronchial smooth muscle excellent adjunct anesthetic agent COPD patient OLV .</brief_summary>
	<brief_title>Effects Dexmedetomidine Respiratory Mechanics Oxygenation During One Lung Ventilation With Chronic Obstructive Lung Disease</brief_title>
	<detailed_description />
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1 . Above 40 year age 2 . American Society Anesthesiologists ( ASA ) Physical Status I , II , III . 3 . COPD diagnose , criterion ( preop . PFT : FEV1 &lt; 80 % , FEV1 / FVC &lt; 70 % bronchodilator ) 4. thoracic surgical procedure 1. severe functional liver kidney disease 2. diagnose HF ( NYHA class &gt; 3 ) 3. arrhythmia receive treatment antiarrythmic drug . 4. exceed BMI &gt; 30 kg/ m2 5. bradycardia ( HR &lt; 50 bpm )</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>